Revision history of "MedChemBio – collective research" (Q11151)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 October 2024

  • curprev 03:5503:55, 11 October 2024DG Regio talk contribs 48,406 bytes +6 Changed label, description and/or aliases in pt
  • curprev 03:5503:55, 11 October 2024DG Regio talk contribs 48,400 bytes −6 Set a claim value: summary (P836): 1. o subprojecto ajudará na fase da produção de drogas avaliadas. produtos para a terapia moderna (LPMT). O objectivo é garantir resultados de qualidade de estudos de pré-validação e válidos, e desenvolver métodos específicos de controlo de qualidade de novos produtos para completar o desenvolvimento e iniciar a produção de LPMT no modo SVP. Incluirá também o lançamento de um estudo destinado a identificar os biomarcadores da eficácia do LPMT.

23 March 2024

15 January 2024

11 June 2023

17 February 2023

2 July 2022

  • curprev 15:1315:13, 2 July 2022DG Regio talk contribs 45,224 bytes +26,154 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, pl, sl, lt, lv, bg, hu, ga, sv, et, cs, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, pl, sl, lt, lv, bg, hu, ga, sv, et,

15 January 2022

14 January 2022

12 December 2021

2 December 2021

  • curprev 08:1508:15, 2 December 2021DG Regio talk contribs 14,955 bytes +1,316 Created claim: summary (P836): 1. Teilprojekt wird in der Produktionsphase von Prüfmedikamenten für fortgeschrittene Therapie (LPMT) helfen. Ziel ist es, qualitativ hochwertige Ergebnisse der Vorvalidierung und validen Studien zu gewährleisten und spezifische Methoden der Qualitätskontrolle neuer Produkte zu entwickeln, um die Entwicklung und den Beginn der Produktion von LPMT im GMP-Modus abzuschließen. Dazu gehört auch die Einleitung einer Studie zur Identifizierung von Bio...
  • curprev 08:1508:15, 2 December 2021DG Regio talk contribs 13,639 bytes +94 Changed label, description and/or aliases in de: translated_label

28 November 2021

  • curprev 09:1409:14, 28 November 2021DG Regio talk contribs 13,545 bytes +1,334 Created claim: summary (P836): 1.sous-projet aidera à la phase de production de médicaments expérimentaux pour la thérapie innovante (LPMT). L’objectif est d’assurer des résultats de qualité de pré-validation et des études valides, et de développer des méthodes spécifiques de contrôle de la qualité des nouveaux produits pour achever le développement et le début de la production de LPMT en mode GMP. Il comprendra également le lancement d’une étude visant à identifier les bioma...
  • curprev 09:1409:14, 28 November 2021DG Regio talk contribs 12,211 bytes +94 Changed label, description and/or aliases in fr: translated_label

27 December 2020

28 October 2020

22 October 2020

  • curprev 15:4015:40, 22 October 2020DG Regio talk contribs 12,566 bytes +1,245 Created claim: summary (P836): 1. subproject will help in the stage of production of evaluated drugs. products for modern therapy (LPMT). The aim is to ensure quality results of pre-validation and valid. studies, and to develop specific methods of quality control of new products to complete development and start production of LPMT in the SVP mode. It will also include the launch of a study aimed at identifying the biomarkers of the efficacy of LPMT. a., translated_summary
  • curprev 15:4015:40, 22 October 2020DG Regio talk contribs 11,321 bytes −784 Removed claim: summary (P836): 1.The subscheme will help in the production phase of advanced therapy products (LPMT). The aim is to ensure the quality of the results of the pre-validation and validation studies and to develop the quality control methods for new products to complete the development and start of the production of the LPMT in GSP. This will include the launch of a study to identify the bio-markers of the efficacy of the LPMT., remove_old_english_translation
  • curprev 06:3206:32, 22 October 2020DG Regio talk contribs 12,105 bytes +93 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 06:3206:32, 22 October 2020DG Regio talk contribs 12,012 bytes −92 Changed label, description and/or aliases in 1 language: remove_english_label

15 July 2020

6 June 2020

25 March 2020

26 February 2020

  • curprev 07:3207:32, 26 February 2020DG Regio talk contribs 10,813 bytes +784 Created claim: summary (P836): 1.The subscheme will help in the production phase of advanced therapy products (LPMT). The aim is to ensure the quality of the results of the pre-validation and validation studies and to develop the quality control methods for new products to complete the development and start of the production of the LPMT in GSP. This will include the launch of a study to identify the bio-markers of the efficacy of the LPMT., Adding English summary

17 February 2020

12 February 2020

6 February 2020

30 January 2020

28 January 2020

16 January 2020

10 January 2020